Dr. Feng Guo
Executive Director and Group Vice President
Toxicology and Pharmacology
Sihuan Pharmaceutical
China
Biography
Dr. Guo, aged 47, brought to the Group nearly 20 years of experiences in innovative drug R&D and management especially in oncology drug R&D strategy making, clinical development, registration etc. In 2000, Dr. Guo obtained his PhD degree in Clinical Pharmacology from the University of Toronto in Canada. In 2001, Dr. Guo joined Pfizer Inc. (“Pfizer”) as associate director at Pfizer Global R&D Headquarter based in Connecticut, US. In 2009, he was the Head of Clinical Pharmacology Asia of Pfizer in China. Since 2011, he was the Head of the Pfizer Wuhan R&D center which he played a key role in building. During his time in Pfizer, Dr. Guo participated in the global development (including in China) of multiple innovative drugs. In 2013, Dr. Guo joined Merck & Co., Inc. (“Merck”) as Vice President of Global R&D and Head of Merck Biopharma (China) R&D Hub, a member of Merck Healthcare Global Clinical Development Executive Leadership team. During his service in Merck, Dr. Guo led his team in clinical development and registration of oncology drugs, including immune-oncology drugs, in China and Asia. In addition, Dr. Guo is an external scientific advisor of the Center for Drug Evaluation of China Food and Drug Administration (“CDE”).
Research Interest
Toxicology, Pharmacology, Pharmaceutticals
